129 related articles for article (PubMed ID: 9259315)
1. The human chorionic somatomammotropin enhancers form a composite silencer in pituitary cells in vitro.
Jiang SW; Eberhardt NL
Mol Endocrinol; 1997 Aug; 11(9):1233-44. PubMed ID: 9259315
[TBL] [Abstract][Full Text] [Related]
2. Human chorionic somatomammotropin enhancer function is mediated by cooperative binding of TEF-1 and CSEF-1 to multiple, low-affinity binding sites.
Jiang SW; Trujillo MA; Eberhardt NL
Mol Endocrinol; 1997 Aug; 11(9):1223-32. PubMed ID: 9259314
[TBL] [Abstract][Full Text] [Related]
3. Human placental TEF-5 transactivates the human chorionic somatomammotropin gene enhancer.
Jiang SW; Wu K; Eberhardt NL
Mol Endocrinol; 1999 Jun; 13(6):879-89. PubMed ID: 10379887
[TBL] [Abstract][Full Text] [Related]
4. Involvement of a protein distinct from transcription enhancer factor-1 (TEF-1) in mediating human chorionic somatomammotropin gene enhancer function through the GT-IIC enhanson in choriocarcinoma and COS cells.
Jiang SW; Eberhardt NL
J Biol Chem; 1995 Jun; 270(23):13906-15. PubMed ID: 7775450
[TBL] [Abstract][Full Text] [Related]
5. The human chorionic somatomammotropin gene enhancer is composed of multiple DNA elements that are homologous to several SV40 enhansons.
Jiang SW; Eberhardt NL
J Biol Chem; 1994 Apr; 269(14):10384-92. PubMed ID: 8144621
[TBL] [Abstract][Full Text] [Related]
6. Binding of AP-2 and ETS-domain family members is associated with enhancer activity in the hypersensitive site III region of the human growth hormone/chorionic somatomammotropin locus.
Jin Y; Norquay LD; Yang X; Gregoire S; Cattini PA
Mol Endocrinol; 2004 Mar; 18(3):574-87. PubMed ID: 14673137
[TBL] [Abstract][Full Text] [Related]
7. Human chorionic somatomammotropin gene enhancer activity is dependent on the blockade of a repressor mechanism.
Lytras A; Cattini PA
Mol Endocrinol; 1994 Apr; 8(4):478-89. PubMed ID: 8052268
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte nuclear factor-3alpha binding at P sequences of the human growth hormone locus is associated with pituitary repressor function.
Norquay LD; Yang X; Jin Y; Detillieux KA; Cattini PA
Mol Endocrinol; 2006 Mar; 20(3):598-607. PubMed ID: 16239259
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific expression and thyroid hormone regulation of the endogenous placental growth hormone variant and chorionic somatomammotropin genes in a human choriocarcinoma cell line.
Nickel BE; Cattini PA
Endocrinology; 1991 May; 128(5):2353-9. PubMed ID: 1708334
[TBL] [Abstract][Full Text] [Related]
10. A TEF-1 binding motif that interacts with a placental protein is important for the transcriptional activity of the hCS-B enhancer.
Jacquemin P; Oury C; Belayew A; Martial JA
DNA Cell Biol; 1994 Oct; 13(10):1037-45. PubMed ID: 7945936
[TBL] [Abstract][Full Text] [Related]
11. TEF-1 transrepression in BeWo cells is mediated through interactions with the TATA-binding protein, TBP.
Jiang SW; Eberhardt NL
J Biol Chem; 1996 Apr; 271(16):9510-8. PubMed ID: 8621623
[TBL] [Abstract][Full Text] [Related]
12. Human TEF-5 is preferentially expressed in placenta and binds to multiple functional elements of the human chorionic somatomammotropin-B gene enhancer.
Jacquemin P; Martial JA; Davidson I
J Biol Chem; 1997 May; 272(20):12928-37. PubMed ID: 9148898
[TBL] [Abstract][Full Text] [Related]
13. Identification of a placental-specific enhancer in the rat placental lactogen II gene that contains binding sites for members of the Ets and AP-1 (activator protein 1) families of transcription factors.
Sun Y; Duckworth ML
Mol Endocrinol; 1999 Mar; 13(3):385-99. PubMed ID: 10076996
[TBL] [Abstract][Full Text] [Related]
14. Differential binding of rat pituitary-specific nuclear factors to the 5'-flanking region of pituitary and placental members of the human growth hormone gene family.
Nickel BE; Nachtigal MW; Bock ME; Cattini PA
Mol Cell Biochem; 1991 Aug; 106(2):181-7. PubMed ID: 1922020
[TBL] [Abstract][Full Text] [Related]
15. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction.
Lytras A; Bock ME; Dodd JG; Cattini PA
Endocrinology; 1994 Jun; 134(6):2461-7. PubMed ID: 7515000
[TBL] [Abstract][Full Text] [Related]
16. Differential placental hormone gene expression during pregnancy in a transgenic mouse containing the human growth hormone/chorionic somatomammotropin locus.
Jin Y; Lu SY; Fresnoza A; Detillieux KA; Duckworth ML; Cattini PA
Placenta; 2009 Mar; 30(3):226-35. PubMed ID: 19168217
[TBL] [Abstract][Full Text] [Related]
17. An initiator element is required for maximal human chorionic somatomammotropin gene promoter and enhancer function.
Jiang SW; Shepard AR; Eberhardt NL
J Biol Chem; 1995 Feb; 270(8):3683-92. PubMed ID: 7876107
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of human placental growth-hormone variant and chorionic somatomammotropin in culture.
Nickel BE; Kardami E; Cattini PA
Biochem J; 1990 May; 267(3):653-8. PubMed ID: 2339980
[TBL] [Abstract][Full Text] [Related]
19. The enhancers of the human placental lactogen B, A, and L genes: progressive activation during in vitro trophoblast differentiation and importance of the DF-3 element in determining their respective activities.
Jacquemin P; Alsat E; Oury C; Belayew A; Muller M; Evain-Brion D; Martial JA
DNA Cell Biol; 1996 Oct; 15(10):845-54. PubMed ID: 8892756
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal architecture and placental expression of the human growth hormone gene family are targeted by pre-pregnancy maternal obesity.
Jin Y; Vakili H; Liu SY; Menticoglou S; Bock ME; Cattini PA
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E435-E445. PubMed ID: 29763375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
